lorazepam has been researched along with clopenthixol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heikkilä, L | 1 |
| Dries, PJ; Hovens, JE; Loonen, AJ; Melman, CT; Wapenaar, RJ | 1 |
| Bildik, T; Ercan, ES; Erermis, S; Gockay, A; Karasoy, H; Tamar, M | 1 |
| Coulier, B; Devresse, A; Gielen, I; Maldague, P; Pierard, F | 1 |
| Adams, CE; Jones, H; Powney, MJ | 1 |
| Harvey, R; Kekulawala, S; Kent, M; Mostafa, S; Tucker, MG | 1 |
1 review(s) available for lorazepam and clopenthixol
| Article | Year |
|---|---|
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
Topics: Aggression; Antipsychotic Agents; Aripiprazole; Clopenthixol; Dystonia; Haloperidol; Humans; Lorazepam; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Sleep; Thiazoles | 2012 |
1 trial(s) available for lorazepam and clopenthixol
| Article | Year |
|---|---|
Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
Topics: Adolescent; Adult; Aged; Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Clopenthixol; Drug Therapy, Combination; Emergency Medical Services; Endpoint Determination; Female; Humans; Lorazepam; Male; Middle Aged; Personnel, Hospital; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Performance; Psychotic Disorders; Risperidone; Social Behavior | 2005 |
4 other study(ies) available for lorazepam and clopenthixol
| Article | Year |
|---|---|
Somatostatin in the cerebrospinal fluid of schizophrenic patients before and after neuroleptic drug treatment.
Topics: Adult; Borderline Personality Disorder; Chronic Disease; Clopenthixol; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Middle Aged; Neurotic Disorders; Psychiatric Status Rating Scales; Psychotropic Drugs; Radioimmunoassay; Schizophrenia; Schizophrenic Psychology; Somatostatin | 1993 |
Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
Topics: Adolescent; Anti-Anxiety Agents; Antidotes; Antipsychotic Agents; Bromocriptine; Clopenthixol; Delayed-Action Preparations; Diazepam; Dopamine Agonists; Female; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lithium Compounds; Lorazepam; Neuroleptic Malignant Syndrome; Treatment Outcome | 2007 |
Focal parietal necrosis of the sigmoid due to atypical neuroleptics: a case report.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Citalopram; Clopenthixol; Dibenzothiazepines; Drug Overdose; Enterocolitis, Necrotizing; Humans; Lamotrigine; Lorazepam; Male; Quetiapine Fumarate; Schizoid Personality Disorder; Trazodone; Triazines | 2012 |
Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report.
Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Chlorpromazine; Clopenthixol; Droperidol; Drug Administration Schedule; Emergency Medical Services; Humans; Hypnotics and Sedatives; Lorazepam; Male; Marijuana Abuse; Methamphetamine; Psychotic Disorders; Time Factors; Treatment Outcome; Violence | 2016 |